Cargando…

Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype

The major cause of failure in cancer chemotherapy is the development of multidrug resistance (MDR), and the characterization of biological factors involved in this response to therapy is particularly needed. A doxorubicin‐resistant HCT‐8/R clone was selected from sensitive parental cells and charact...

Descripción completa

Detalles Bibliográficos
Autores principales: Cinci, Lorenzo, Luceri, Cristina, Bigagli, Elisabetta, Carboni, Ilaria, Paccosi, Sara, Parenti, Astrid, Guasti, Daniele, Coronnello, Marcella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924386/
https://www.ncbi.nlm.nih.gov/pubmed/27016279
http://dx.doi.org/10.1002/cam4.694
_version_ 1782439864522768384
author Cinci, Lorenzo
Luceri, Cristina
Bigagli, Elisabetta
Carboni, Ilaria
Paccosi, Sara
Parenti, Astrid
Guasti, Daniele
Coronnello, Marcella
author_facet Cinci, Lorenzo
Luceri, Cristina
Bigagli, Elisabetta
Carboni, Ilaria
Paccosi, Sara
Parenti, Astrid
Guasti, Daniele
Coronnello, Marcella
author_sort Cinci, Lorenzo
collection PubMed
description The major cause of failure in cancer chemotherapy is the development of multidrug resistance (MDR), and the characterization of biological factors involved in this response to therapy is particularly needed. A doxorubicin‐resistant HCT‐8/R clone was selected from sensitive parental cells and characterized analyzing several parameters (cell cycle phase distribution, apoptotic activity, expression, distribution and functionality of the P‐gp efflux pump, the response to other chemotherapy agents, its ultrastructural features, invasiveness, and transcriptomic profile). HCT‐8/R cells showed a peculiar S phase distribution, characterized by a single pulse of proliferation, resistance to drug‐mediated apoptosis, increased expression and functionality of P‐gp and overexpression of stem cell markers (CD44 and aldehyde dehydrogenase 1A2). At the ultrastructural level, HCT‐8/R presented a greater cell volume and several intracytoplasmic vesicles respect to HCT‐8. Moreover, the resistant clone was characterized by cross resistance to other cytotoxic drugs and a greater capacity for migration and invasion, compared to parental cells. Our data reinforce the concept that the MDR phenotype in HCT‐8/R cells is multifactorial and involves multiple mechanisms, representing an interesting tool to understand the biological basis of MDR and to test strategies that overcome resistance to chemotherapy.
format Online
Article
Text
id pubmed-4924386
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-49243862016-06-29 Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype Cinci, Lorenzo Luceri, Cristina Bigagli, Elisabetta Carboni, Ilaria Paccosi, Sara Parenti, Astrid Guasti, Daniele Coronnello, Marcella Cancer Med Cancer Biology The major cause of failure in cancer chemotherapy is the development of multidrug resistance (MDR), and the characterization of biological factors involved in this response to therapy is particularly needed. A doxorubicin‐resistant HCT‐8/R clone was selected from sensitive parental cells and characterized analyzing several parameters (cell cycle phase distribution, apoptotic activity, expression, distribution and functionality of the P‐gp efflux pump, the response to other chemotherapy agents, its ultrastructural features, invasiveness, and transcriptomic profile). HCT‐8/R cells showed a peculiar S phase distribution, characterized by a single pulse of proliferation, resistance to drug‐mediated apoptosis, increased expression and functionality of P‐gp and overexpression of stem cell markers (CD44 and aldehyde dehydrogenase 1A2). At the ultrastructural level, HCT‐8/R presented a greater cell volume and several intracytoplasmic vesicles respect to HCT‐8. Moreover, the resistant clone was characterized by cross resistance to other cytotoxic drugs and a greater capacity for migration and invasion, compared to parental cells. Our data reinforce the concept that the MDR phenotype in HCT‐8/R cells is multifactorial and involves multiple mechanisms, representing an interesting tool to understand the biological basis of MDR and to test strategies that overcome resistance to chemotherapy. John Wiley and Sons Inc. 2016-03-25 /pmc/articles/PMC4924386/ /pubmed/27016279 http://dx.doi.org/10.1002/cam4.694 Text en © 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Biology
Cinci, Lorenzo
Luceri, Cristina
Bigagli, Elisabetta
Carboni, Ilaria
Paccosi, Sara
Parenti, Astrid
Guasti, Daniele
Coronnello, Marcella
Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype
title Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype
title_full Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype
title_fullStr Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype
title_full_unstemmed Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype
title_short Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype
title_sort development and characterization of an in vitro model of colorectal adenocarcinoma with mdr phenotype
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924386/
https://www.ncbi.nlm.nih.gov/pubmed/27016279
http://dx.doi.org/10.1002/cam4.694
work_keys_str_mv AT cincilorenzo developmentandcharacterizationofaninvitromodelofcolorectaladenocarcinomawithmdrphenotype
AT lucericristina developmentandcharacterizationofaninvitromodelofcolorectaladenocarcinomawithmdrphenotype
AT bigaglielisabetta developmentandcharacterizationofaninvitromodelofcolorectaladenocarcinomawithmdrphenotype
AT carboniilaria developmentandcharacterizationofaninvitromodelofcolorectaladenocarcinomawithmdrphenotype
AT paccosisara developmentandcharacterizationofaninvitromodelofcolorectaladenocarcinomawithmdrphenotype
AT parentiastrid developmentandcharacterizationofaninvitromodelofcolorectaladenocarcinomawithmdrphenotype
AT guastidaniele developmentandcharacterizationofaninvitromodelofcolorectaladenocarcinomawithmdrphenotype
AT coronnellomarcella developmentandcharacterizationofaninvitromodelofcolorectaladenocarcinomawithmdrphenotype